ResultsIQ

ResultsIQ › Latest results › Viyash Scientific Limited

Viyash Scientific Limited Q4 FY26 earnings call summary

NSE: VIYASH · BSE: 512529

Earnings call of 20 May 2026, summarised by AI from the filing.

Innovator life cycle management business expected to grow 40% in FY27 on base of ₹200-225 cr.

Key takeaways

  1. FY27 guidance Innovator life cycle management business expected to grow 40% in FY27 on base of ₹200-225 cr.
  2. Growth driver Companion animal expansion with BI partnership and R&D expansion to increase product development by 5-6x.
  3. Raw material risk Solvent availability and freight costs impacted by geopolitical issues; managing with inventory and price increases.

Original filing on BSE

Viyash Scientific Limited Q1 FY27 results

As filed: Revenue ₹946 cr, EBITDA ₹178 cr, PAT ₹79.3 cr, EBITDA margin 18.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹946 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹920 cr, EBITDA ₹184 cr, PAT ₹66.4 cr, EBITDA margin 20.0%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹920 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.0% in 30 days (Nifty 500: +3.0%).
  • Q3 FY26: Revenue ₹858 cr, EBITDA ₹176 cr, PAT ₹48.5 cr, EBITDA margin 20.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹858 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +11.7% in 30 days (Nifty 500: +2.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Viyash Scientific Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.